• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, in British Columbia, Canada

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Mar 30;27(6).
doi: 10.3201/eid2706.210532. Online ahead of print.
Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, in British Columbia, Canada

Nancy Matic, Christopher F Lowe, Gordon Ritchie, Aleksandra Stefanovic, Tanya Lawson, Willson Jang, Matthew Young, Winnie Dong, Zabrina L Brumme, Chanson J Brumme, Victor Leung, Marc G Romney

Abstract

To screen all severe acute respiratory syndrome coronavirus 2-positive samples in British Columbia, Canada, and determine whether they represented variants of concern, we implemented a real-time reverse transcription PCR-based algorithm. We rapidly identified 77 samples with variants: 57 with B.1.1.7, 7 with B.1.351, and an epidemiologic cluster of 13 with B.1.1.28/P.1.

Keywords: 2019 novel coronavirus disease; B.1.1.28/P.1; British Columbia; COVID-19; Canada; K417N; N501Y; SARS-CoV-2; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; spike; viruses; zoonoses.
 
Back
Top Bottom